Stock listing
AKTS Stock Price, News, Filings & Events — Aktis Oncology, Inc.
Selected listing: AKTS · BOATS · USD · US
This page tracks Aktis Oncology, Inc.'s AKTS:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following AKTS:BOATS. AKTS:BOATS is the stock-level entry point for investors researching Aktis Oncology, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Aktis Oncology, Inc. is a public company listed under the ticker AKTS, operating in the American market. The company has a market capitalization of approximately $1.38 billion. Aktis Oncology focuses on developing innovative cancer therapies to improve patient outcomes.
- Ticker
- AKTS:BOATS
- Asset type
- Stock
- Market cap
- $1.30B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- BOATS
- Currency
- USD
Aktis Oncology, Inc. AKTS:BOATS stock context
This page tracks Aktis Oncology, Inc.'s AKTS:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following AKTS:BOATS. AKTS:BOATS is the stock-level entry point for investors researching Aktis Oncology, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Aktis Oncology, Inc. is a public company listed under the ticker AKTS, operating in the American market. The company has a market capitalization of approximately $1.38 billion. Aktis Oncology focuses on developing innovative cancer therapies to improve patient outcomes.
Latest news from Aktis Oncology, Inc.
Aktis Oncology to Present at Upcoming September Investor Conferences
September 9, 2026
Aktis Oncology Reports Financial Results and Business Highlights for the Second Quarter 2026
August 13, 2026
Aktis Oncology to Present at the Jefferies Global Healthcare Conference
May 27, 2026
Aktis Oncology Reports First-in-Human Clinical Imaging and Dosimetry Data for AKY-2519 Demonstrating Robust Tumor Uptake and Limited Norm...
May 21, 2026
Aktis Oncology Reports Financial Results and Business Highlights for First Quarter 2026
May 11, 2026
Aktis Oncology, Inc. earnings calls
Aktis Oncology, Inc. (AKTS) Q3 2024 Earnings Call
May 13, 2024 · Replay with transcript and chapters
Aktis Oncology, Inc. (AKTS) Q2 2024 Earnings Call
February 13, 2024 · Replay with transcript and chapters
Aktis Oncology, Inc. (AKTS) Q1 2024 Earnings Call
November 13, 2023 · Replay with transcript and chapters
Aktis Oncology, Inc. (AKTS) Q4 2023 Earnings Call
September 6, 2023 · Replay with transcript and chapters
Aktis Oncology, Inc. (AKTS) Q3 2023 Earnings Call
May 8, 2023 · Replay with transcript and chapters
Aktis Oncology, Inc. (AKTS) Q2 2023 Earnings Call
February 7, 2023 · Replay with transcript and chapters
Research Aktis Oncology, Inc.
Aktis Oncology, Inc. investor report
Review AI stock analysis and investor report context for AKTS:BOATS.
Aktis Oncology, Inc. company profile
View the public company page for Aktis Oncology, Inc. on 6ix.
Aktis Oncology, Inc. news
Read company news and market updates connected to Aktis Oncology, Inc..
Aktis Oncology, Inc. investor events
Find investor webinars, events, and replay context for Aktis Oncology, Inc..